LIVE FROM THE DATABASETRANSACTIONS 723,502COMPANIES 6,572LATEST TRADE Oct 27UPDATED Oct 27, 11:15 PM

Reporting ownerCIK 0001967168

Samuel Kintz

20 transactions in one company, from February 6, 2025 to November 17, 2025.

Transactions: 201 company
Bought · P: $0open market
Sold · S: $2.3Mopen market
Net: −$2.3Mnet selling

By company

Where this insider traded.

Company	Ticker	Trades	Bought	Sold
Enliven Therapeutics, Inc.	ELVN	20	—	$2.3M

All transactions

20 in total, newest filings first.

Company	Ticker	Insider	Date	Code	Shares	Price	Value	Held after
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Nov 17	SPLAN	12,500	$21.82	$273K	890,392
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Oct 17	SPLAN	12,500	$21.33	$267K	902,892
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Sep 26	SPLAN	3,700	$20.06	$74K	915,392
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Sep 23	SPLAN	2,800	$20.03	$56K	919,092
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Sep 19	SPLAN	1,000	$20.25	$20K	921,892
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Sep 17	SPLAN	5,000	$19.09	$95K	922,892
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Aug 19	SPLAN	590	$20.00	$12K	929,409
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Aug 18	SPLAN	10,393	$20.02	$208K	929,999
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Jul 17	SPLAN	3,663	$23.37	$86K	940,392
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Jul 17	SPLAN	4,687	$22.69	$106K	944,055
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Jul 17	SPLAN	4,150	$21.58	$90K	948,742
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Jun 17	SPLAN	1,998	$22.75	$45K	952,892
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Jun 17	SPLAN	10,502	$22.08	$232K	954,890
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Jun 3	SPLAN	7,500	$20.05	$150K	965,392
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	May 19	SPLAN	5,000	$16.49	$82K	972,892
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	May 2	SPLAN	2,170	$20.00	$43K	977,892
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	May 1	SPLAN	5,330	$20.08	$107K	980,062
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Apr 17	SPLAN	5,000	$16.42	$82K	985,392
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEO	Mar 17	SPLAN	12,500	$20.83	$260K	990,392
Enliven Therapeutics, Inc.	ELVN	Samuel KintzCEODERIV	Feb 6	AAward	490,000	$0.00	—?	490,000derivatives